Bristol Myers CEO on Biontech deal: Next new frontier in treatment of cancer

Bristol Myers Squibb CEO: Richest product pipeline we've had in the last decade

Pharma exec won't commit to selling life-saving drug in U.S. for lower price offered in Canada

Pharmaceutical CEOs testify before Senate panel on drug prices | full video

Bristol Myers Squibb | Global Patient Week 2023: LinkedIn Live

Bristol Myers Squibb CEO on $11B cancer drug deal with BioNTech

The Hot at Nights - "Seasons"